How do I contact Jasper Bos?

Jasper Bos, General Partner at Forbion, can be reached by email. The verified email address is listed on this page.

What is Jasper Bos's email address?

Jasper Bos's email address uses the forbion.com domain (shown as *****@forbion.com until revealed).

What does Jasper Bos invest in?

Jasper Bos backs Health tech companies at Series A and Seed, typically writing €92k–€4.6M cheques.

How do I cold email Jasper Bos?

Jasper Bos backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. A concise cold email that leads with relevant traction and one specific ask, sent to the verified address on this page, is the most direct way to reach Jasper.

Where is Jasper Bos based?

Jasper Bos is based in Amsterdam, Netherlands and works at Forbion.

Jasper Bos Email & Contact Information

General Partner @ Forbion

Show Jasper's email

Jasper Bos Location

Amsterdam, Netherlands

Jasper Bos Investing

General Partner at Forbion

Stages: Series A, Seed
Sectors: Health tech
Cheque size: €92k–€4.6M
Freshness: Verified 1mo ago

Jasper Bos Summary

Jasper Bos, based in Amsterdam, Netherlands, is a General Partner at Forbion. Jasper Bos invests in Health tech at Series A and Seed, writing €92k–€4.6M cheques. Jasper Bos's verified email and contact details are available on Mintround.

How to cold email Jasper Bos

Jasper Bos, Forbion in Amsterdam, Netherlands, backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. Here's how to get a reply when you cold email Jasper:

Subject line: name your company and one metric that matters to Health tech, not “quick chat”.
First line: your strongest traction, the real numbers, not adjectives.
One ask: a 20-minute call with a date range. Keep it under 150 words.
Send it to Jasper's verified address below. No warm intro required.

Show Jasper's email

Notable investments

Braveheart BioSeries A · $190M · 2025
CellCentricSeries C · $120M · 2025
Engrail TherapeuticsSeries B · $160M · 2024
PrecirixSeries B · $88M · 2022
AnaveonSeries B · $120M · 2021
Inthera BioscienceSeries A · $5M · 2018
Prexton TherapeuticsSeries B · $31M · 2017
ARTSaVITSeries A · $6M · 2017

Frequently co-invests with

Ohad HammerPontifax Venture Capital2×Alan O'ConnellSeroba Life SciencesDenis PatrickPfizer Venture InvestmentsFlorian MüllershausenNovartis Venture FundHeath LukatchRed Tree Venture CapitalKeno Gutierrez (BGV (BioGeneration Ventures))Laura StoppelRA CapitalMarco BoorsmaForbionMark KrulAglaia BioMedical VenturesMarten SteenHealthCapNanna LuneborgForbionNiall O’DonnellRiverVest

Jasper Bos's colleagues at Forbion

Rogier RooswinkelPartner, Forbion

Sander SlootwegManaging Partner, Forbion

Wouter JoustraGeneral Partner, Forbion

Antoine Boulanger PietteAssociate, Forbion

Audrey CacalySenior Associate, Forbion

Dmitrij HristodorovPartner, Forbion

Dirk KerstenGeneral Partner, Forbion

Geert-Jan MulderManaging Partner, Forbion

Holger ReithingerGeneral Partner, Forbion

Marco BoorsmaGeneral Partner, Forbion

Martien van OschManaging Partner, Forbion

Nanna LuneborgGeneral Partner, Forbion

See all 13 at Forbion →

Similar investors

Diede BrunenSenior Associate, BGV (BioGeneration Ventures)

Antoine Boulanger PietteAssociate, Forbion

Robin van BoxselPartner, FORWARD.one

Clement SalqueAnalyst, Bioqube Ventures